Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Howe

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Molecular Graphics|June 1, 1989
A fast algorithm for generating smooth molecular dot surface representationsJ B Moon, W J Howe
Proteins|January 1, 1991
Computer design of bioactive molecules: a method for receptor-based de novo ligand designJ B Moon, W J Howe
The Journal of Biological Chemistry|February 17, 1995
CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymesA J Hoogewerf, J W Leone, I M Reardon, et al.
Protein Science : a Publication of the Protein Society|December 1, 1993
Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral proteaseA G Tomasselli, J L Sarcich, L J Barrett, et al.
Proteins|January 1, 1991
Calcium-free calmodulin is a substrate of proteases from human immunodeficiency viruses 1 and 2A G Tomasselli, W J Howe, J O Hui, et al.
Analytical Chemistry|July 15, 1995
Protein binding chiral discrimination of HPLC stationary phases made with whole, fragmented, and third domain turkey ovomucoidT C Pinkerton, W J Howe, E L Ulrich, et al.
International Journal of Peptide and Protein Research|September 1, 1992
HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogsT K Sawyer, D J Staples, L Liu, et al.
Protein Science : a Publication of the Protein Society|August 1, 1992
Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modelingN Thanki, J K Rao, S I Foundling, et al.
Journal of Medicinal Chemistry|August 1, 1991
Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activityS Thaisrivongs, A G Tomasselli, J B Moon, et al.
Journal of Medicinal Chemistry|September 1, 1995
Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitorsS Thaisrivongs, K D Watenpaugh, W J Howe, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Molecular Graphics|June 1, 1989
A fast algorithm for generating smooth molecular dot surface representationsJ B Moon, W J Howe
Proteins|January 1, 1991
Computer design of bioactive molecules: a method for receptor-based de novo ligand designJ B Moon, W J Howe
The Journal of Biological Chemistry|February 17, 1995
CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymesA J Hoogewerf, J W Leone, I M Reardon, et al.
Protein Science : a Publication of the Protein Society|December 1, 1993
Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral proteaseA G Tomasselli, J L Sarcich, L J Barrett, et al.
Proteins|January 1, 1991
Calcium-free calmodulin is a substrate of proteases from human immunodeficiency viruses 1 and 2A G Tomasselli, W J Howe, J O Hui, et al.
Analytical Chemistry|July 15, 1995
Protein binding chiral discrimination of HPLC stationary phases made with whole, fragmented, and third domain turkey ovomucoidT C Pinkerton, W J Howe, E L Ulrich, et al.
International Journal of Peptide and Protein Research|September 1, 1992
HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogsT K Sawyer, D J Staples, L Liu, et al.
Protein Science : a Publication of the Protein Society|August 1, 1992
Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modelingN Thanki, J K Rao, S I Foundling, et al.
Journal of Medicinal Chemistry|August 1, 1991
Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activityS Thaisrivongs, A G Tomasselli, J B Moon, et al.
Journal of Medicinal Chemistry|September 1, 1995
Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitorsS Thaisrivongs, K D Watenpaugh, W J Howe, et al.
Pageof 3